Dr. Lynn Eschenbacher, PharmD, MBA, FASHP, CPEL
As an innovative executive driving positive outcomes and profitability, Dr. Eschenbacher is focused on addressing healthcare access and equity. As CEO and Founder of Echelon Health Strategies, she develops and delivers innovative strategies, operational excellence, and relationship networking to drive growth resulting in positive business outcomes and profitability. Among her many accomplishments, Dr. Eschenbacher was Chief Pharmacy Officer and VP of Medication Management at Ascension Healthcare, the second largest non-profit health system in the United States.
Dr. David Dalton, PharmD, MBA, FASHP, CPEL
Dr. Dalton is a Hall of Fame CEO, entrepreneur, pharmaceutical executive, and founder of over 40 companies. He is currently Board Director and Executive Chairman of six companies and leads the chain drug industry as the first black executive. His accolades include being an inductee in three halls of fame and a recipient of the Senatorial Medal of Freedom. Dr. Dalton was also selected by the International Forum on Advancement in Healthcare (IFAH) as one of the "Top 100 Healthcare Leaders" in 2019 and "Top 100 Healthcare Visionaries Award" in 2021.
Richard Serbin, JD, RPh, LLM
Mr. Serbin was the Chief FDA Counsel for Revlon Corporation and Johnson & Johnson Corporation. He held senior management roles at Johnson & Johnson and served on the Board of Directors of numerous Johnson & Johnson subsidiary companies including Ethicon, Ortho, Johnson & Johnson Consumer Products, Pittman-Moore, McNeil and Johnson & Johnson Development Corporationn. His broader experience includes serving on the boards of numerous other companies involved in biotechnology, dermatology, veterinary medicine, female healthcare, medical devices, photodynamic therapy, surgical and consumer products.